Showing results (2011-2020 of 2,138) with videos related to
Sort By:
Pageof 214
JAMA Oncology|March 28, 2024
Tumor Intrinsic Subtypes and Gene Expression Signatures in Early-Stage ERBB2/HER2-Positive Breast Cancer: A Pooled Analysis of CALGB 40601, NeoALTTO, and NSABP B-41 TrialsAranzazu Fernandez-Martinez, Mattia Rediti, Gong Tang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 11, 2024
Adjuvant Pertuzumab and Trastuzumab in Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in the APHINITY Trial: Third Interim Overall Survival Analysis With Efficacy UpdateSibylle Loibl, Jacek Jassem, Amir Sonnenblick, et al.Ebiomedicine|May 8, 2024
Association between endocrine adjuvant therapy intake timing and disease-free survival in patients with high-risk early breast cancer: results of a sub-study of the UCBG- UNIRAD trialSylvie Giacchetti, Enora Laas, Thomas Bachelot, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2023
Comparison of Circulating Tumor DNA Assays for Molecular Residual Disease Detection in Early-Stage Triple-Negative Breast CancerMaria Coakley, Guillermo Villacampa, Prithika Sritharan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 11, 2023
Effect of Metformin Versus Placebo on New Primary Cancers in Canadian Cancer Trials Group MA.32: A Secondary Analysis of a Phase III Randomized Double-Blind Trial in Early Breast CancerPamela J Goodwin, Bingshu E Chen, Karen A Gelmon, et al.JAMA Oncology|August 2, 2019
Assessment of Molecular Relapse Detection in Early-Stage Breast CancerIsaac Garcia-Murillas, Neha Chopra, Iñaki Comino-Méndez, et al.American Journal of Veterinary Research|April 2, 2011
Evaluation of a fibrillin 2 gene haplotype associated with hip dysplasia and incipient osteoarthritis in dogsSteven G Friedenberg, Lan Zhu, Zhiwu Zhang, et al.Breast Cancer Research and Treatment|November 15, 2014
NEOCENT: a randomised feasibility and translational study comparing neoadjuvant endocrine therapy with chemotherapy in ER-rich postmenopausal primary breast cancerC Palmieri, S Cleator, L S Kilburn, et al.The New England Journal of Medicine|August 27, 2005
A pooled analysis of bone marrow micrometastasis in breast cancerStephan Braun, Florian D Vogl, Bjørn Naume, et al.Global Change Biology|March 13, 2020
Critical land change information enhances the understanding of carbon balance in the United StatesJinxun Liu, Benjamin M Sleeter, Zhiliang Zhu, et al.Pageof 214